Screening patients with scleroderma for pulmonary arterial hypertension and implications for other at-risk populations
Pulmonary arterial hypertension (PAH) is a progressive vasculopathy that is advanced by the time symptoms develop. As symptoms are nonspecific and the condition uncommon, continued progression toward end-stage disease occurs for an average of 2 years between symptom onset and diagnosis. There is nee...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2013-12-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/22/130/515.full.pdf+html |